Determinants of virological outcome and adverse events in African children treated with paediatric nevirapine fixed-dose-combination tablets
<strong>Background:</strong> Nevirapine is the only non-nucleoside reverse transcriptase inhibitor currently available as a paediatric fixed-dose combination tablet and is widely used in African children. Nonetheless, the number of investigations into pharmacokinetic determinants of viro...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
Lippincott, Williams & Wilkins
2017
|